Senior insider sale
Chief Executive Officer at MONOPAR THERAPEUTICS — senior position signals high conviction
$2.60M
29.06K shares
What this filing means
ROBINSON CHANDLER plans to sell 29.06K shares of MONOPAR THERAPEUTICS valued at approximately $2.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/24/2026ACC: 0001950047-26-009797
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
29.06K
Shares to sell
$2.60M
Approx. market value
29.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/24/2026
29.06KTotal acquired29.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/24/2026 | Exercise of Stock Options Cash | 29.06K | — |
| Total | 29.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
29.06K
Market value
$2.60M
9/24/2026
Total
Units
29.06K
Value
$2.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/24/2026 | 29.06K | $2.60M | NASDAQ | Planned |
| Total | 29.06K | $2.60M | ||